Marascio Nadia, Costantino Angela, Taffon Stefania, Lo Presti Alessandra, Equestre Michele, Bruni Roberto, Pisani Giulio, Barreca Giorgio Settimo, Quirino Angela, Trecarichi Enrico Maria, Costa Chiara, Mazzitelli Maria, Serapide Francesca, Matera Giovanni, Torti Carlo, Liberto Maria Carla, Ciccaglione Anna Rita
Department of Health Sciences, Institute of Microbiology, "Magna Grecia" University, 88100 Catanzaro, Italy.
Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
J Clin Med. 2021 Apr 13;10(8):1655. doi: 10.3390/jcm10081655.
Hepatitis C virus subtype 1b (HCV1b) is still the most prevalent subtype worldwide, with massive expansion due to poor health care standards, such as blood transfusion and iatrogenic procedures. Despite safe and effective new direct antiviral agents (DAA), treatment success can depend on resistance-associated substitutions (RASs) carried in target genomic regions. Herein we investigated transmission clusters and RASs among isolates from HCV1b positive subjects in the Calabria Region. Forty-one NS5B and twenty-two NS5A sequences were obtained by Sanger sequencing. Phylogenetic analysis was performed using the maximum likelihood method and resistance substitutions were analyzed with the Geno2pheno tool. Phylogenetic analysis showed sixteen statistically supported clusters, with twelve containing Italian sequences mixed with foreign HCV1b isolates and four monophyletic clusters including only sequences from Calabria. Interestingly, HCV1b spread has been maintained by sporadic infections in geographically limited areas and by dental treatment or surgical intervention in the metropolitan area. The L159F NS5B RAS was found in 15 isolates and in particular 8/15 also showed the C316N substitution. The Y93H and L31M NS5A RASs were detected in three and one isolates, respectively. The A92T NS5A RAS was found in one isolate. Overall, frequencies of detected NS5B and NS5A RASs were 36.6% and 22.7%, respectively. For the eradication of infection, improved screening policies should be considered and the prevalence of natural RASs carried on viral strains.
丙型肝炎病毒1b型(HCV1b)仍是全球最普遍的亚型,由于医疗保健标准不佳,如输血和医源性操作,导致其大量传播。尽管有安全有效的新型直接抗病毒药物(DAA),治疗成功与否可能取决于靶基因组区域携带的耐药相关替代(RAS)。在此,我们调查了卡拉布里亚地区HCV1b阳性受试者分离株中的传播簇和RAS。通过桑格测序获得了41个NS5B和22个NS5A序列。使用最大似然法进行系统发育分析,并用Geno2pheno工具分析耐药替代。系统发育分析显示有16个统计学支持的簇,其中12个包含意大利序列与国外HCV1b分离株混合,4个单系簇仅包含来自卡拉布里亚的序列。有趣的是,HCV1b的传播通过地理上有限区域的散发性感染以及大都市地区的牙科治疗或外科干预得以维持。在15个分离株中发现了L159F NS5B RAS,特别是8/15还显示出C316N替代。Y93H和L31M NS5A RAS分别在3个和1个分离株中检测到。在1个分离株中发现了A92T NS5A RAS。总体而言,检测到的NS5B和NS5A RAS的频率分别为36.6%和22.7%。为了根除感染,应考虑改进筛查政策以及病毒株携带的天然RAS的流行情况。